# Traws Pharma (TRAW) — Earnings

TRAW · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/traw/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.11 |
| EPS estimate | −$8.75 |
| EPS surprise | +98.74% |
| Revenue surprise | +4455.00% |
| Revenue | $2.7M |
| Revenue estimate | $60,000.00 |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1130598/000155837025011469/tmb-20250630x10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/a1f4add1-87f6-166d-282d-9cd9e938a2da.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | −$8.75 | −$0.11 | 98.74% | $60,000.00 | $2.7M |
| Q1 2025 | May 15, 2025 | −$8.04 | $2.09 | 126.00% | $60,000.00 | $57,000.00 |
| Q4 2024 | Mar 31, 2025 | −$9.55 | $101.35 | 1161.26% | $60,000.00 | $56,000.00 |
| Q3 2024 | Nov 14, 2024 | −$6.25 | −$8.81 | -40.96% | $60,000.00 | $57,000.00 |
| Q2 2024 | Aug 15, 2024 | −$6.25 | −$121.75 | -1848.00% | $60,000.00 | $57,000.00 |
| Q1 2024 | May 15, 2024 | −$5.88 | −$6.00 | -2.13% | $60,000.00 | $56,000.00 |
| Q4 2023 | Apr 1, 2024 | −$6.33 | −$4.75 | 25.00% | $65,333.00 | $56,000.00 |
| Q3 2023 | Nov 14, 2023 | −$7.25 | −$5.75 | 20.69% | $69,250.00 | $57,000.00 |
| Q2 2023 | Aug 10, 2023 | −$7.81 | −$5.00 | 36.00% | $69,250.00 | $57,000.00 |
| Q1 2023 | May 15, 2023 | −$7.44 | −$7.00 | 5.88% | $79,000.00 | $56,000.00 |
| Q4 2022 | Mar 16, 2023 | −$6.94 | −$6.50 | 6.31% | $80,000.00 | $46,000.00 |
| Q3 2022 | Nov 14, 2022 | −$5.31 | −$6.50 | -22.35% | $73,667.00 | $57,000.00 |
| Q2 2022 | Aug 11, 2022 | −$4.94 | −$4.75 | 3.80% | $73,000.00 | $57,000.00 |
| Q1 2022 | May 11, 2022 | −$4.69 | −$5.00 | -6.67% | $79,000.00 | $56,000.00 |
| Q4 2021 | Mar 17, 2022 | −$6.75 | −$4.25 | 37.04% | $59,500.00 | $56,000.00 |
| Q3 2021 | Nov 12, 2021 | −$8.17 | −$5.50 | 32.65% | $53,333.00 | $57,000.00 |
| Q2 2021 | Aug 12, 2021 | −$7.13 | −$6.75 | 5.26% | $20,000.00 | $57,000.00 |
| Q1 2021 | May 17, 2021 | −$11.25 | −$7.50 | 33.33% | $60,000.00 | $56,000.00 |
| Q4 2020 | Mar 11, 2021 | −$12.50 | −$15.00 | -20.00% | $45,000.00 | $51,000.00 |
| Q3 2020 | Nov 12, 2020 | −$12.50 | −$11.25 | 10.00% | $1.4M | $66,000.00 |

## Frequently Asked Questions

### When did Traws Pharma (TRAW) last report earnings?

Traws Pharma last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did TRAW beat earnings estimates?

Yes. Traws Pharma reported EPS of −$0.11 for Q2 2025 against a −$8.75 estimate — a 98.74% beat.

### How much revenue did TRAW report last quarter?

Traws Pharma reported $2.7M in revenue for Q2 2025, against a consensus estimate of $60,000.00.

## Similar Stocks

- [SLGL](https://www.lighthorse.io/tickers/slgl) — Sol-Gel Technologies Ltd. - Ordinary Shares

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).